Go Pro
NASDAQ:HRTS

Tema Heart & Health ETF (HRTS) Price, Holdings, & News

Tema Heart & Health ETF logo
$36.03 -0.51 (-1.40%)
Closing price 03:59 PM Eastern
Extended Trading
$35.98 -0.05 (-0.14%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Tema Heart & Health ETF (NASDAQ:HRTS)

Advanced

Key Stats

Today's Range
$35.98
$36.43
50-Day Range
$35.90
$38.87
52-Week Range
$29.54
$38.87
Volume
2,595 shs
Average Volume
5,623 shs
Market Capitalization
$53.32 million
Assets Under Management
$54.09 million
Dividend Yield
N/A
Net Expense Ratio
0.75%
Aggregate Rating
Moderate Buy

ETF Overview

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.

Tema Heart & Health ETF Expenses

TypeHRTSTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.99%0.57%0.57%0.54%0.53%
Other Expenses0.00%0.57%0.53%0.38%0.54%
Total Expense0.99%0.72%0.75%0.69%0.73%
Fee Waiver-0.24%-0.72%-0.67%-0.41%-0.68%
Net Expense0.75%0.60%0.63%0.61%0.60%
Receive HRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tema Heart & Health ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HRTS ETF News Headlines

Tema Heart & Health ETF (HRTS)
Tema ETF Trust - Tema Heart & Health ETF
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
TEMA HEART & HEALTH ETF ETFs | Markets Insider
HRTS Tema Obesity & Cardiometabolic ETF
See More Headlines

HRTS ETF - Frequently Asked Questions

Tema Heart & Health ETF's stock was trading at $35.29 on January 1st, 2026. Since then, HRTS shares have increased by 2.1% and is now trading at $36.03.

Top institutional investors of Tema Heart & Health ETF include Sterling Investment Advisors Ltd. (8.35%), Rothschild Capital Partners LLC (1.65%), Members Advisory Group LLC (1.37%) and Anson Capital Inc. (1.02%).

Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tema Heart & Health ETF investors own include Scilex (SCLX), Rigetti Computing (RGTI), Pfizer (PFE), BlackBerry (BB), Butterfly Network (BFLY), BioNTech (BNTX) and Gold.com (GOLD).

Fund Details

Issuer
Tema Global
Fund Name
Tema Heart & Health ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:HRTS
Inception Date
11/20/2023
Fund Manager
David Song, Yuri Khodjamirian
Previous Symbol
NASDAQ:HRTS
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
48

Fund Statistics

Assets Under Management
$54.09 million
Average Daily Volume
$0.00
Discount/Premium
-0.01%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Tema ETFs LLC
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bancorp Fund Services, LLC
Trustee
N/A
Lead Market Maker
Virtu Financial

Miscellaneous

Beta
0.63
Creation Unit
10,000
Creation Fee
$500.00
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Top 10 HRTS Holdings

HRTS Sector Exposure

HRTS Industry Exposure


This page (NASDAQ:HRTS) was last updated on 9/23/2026 by MarketBeat.com Staff.
From Our Partners